Current concepts in psoriasis and its treatment (Q35187758)

7 August 2017

1 reference

title

Current concepts in psoriasis and its treatment (English)

1 reference

7 August 2017

Mendonça CO

1 reference

7 August 2017

Burden AD

series ordinal

1 reference

7 August 2017

publication date

1 August 2003

1 reference

Pharmacology & Therapeutics

7 August 2017

published in

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

133-147

1 reference

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

British Photodermatology Group guidelines for PUVA

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

308-nm excimer laser for the treatment of psoriasis: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Urinary adenosine and aminoimidazolecarboxamide excretion in methotrexate-treated patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinoc

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Treatment of psoriasis with oral liarozole: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Biological effects of cyclosporin A: A new antilymphocytic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Searching for Psoriasis Susceptibility Genes in Italy: Genome Scan and Evidence for a New Locus on Chromosome 1

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Psoriasis in Australian twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Treatment of psoriasis with azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Effects of 8-methoxypsoralen-induced phototoxic effects on mammalian epidermal macromolecule synthesis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Dithranol upregulates IL-10 receptors on the cultured human keratinocyte cell line HaCaT.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Validation of Sickness Impact Profile and Psoriasis Disability Index in Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in Psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Lepra, psora, psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Oral retinoids--efficacy and toxicity in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Psoriasis. Immunopathology and immunomodulation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Kinetics of photosensitivity in bath-PUVA photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Sulfasalazine improves psoriasis. A double-blind analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Decreased natural-killer-cell activity in cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Acitretin in psoriasis: an overview of adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Fumaric acid therapy in psoriasis: results and side effects of 2 years of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Therapeutic photoimmunology: photoimmunological mechanisms in photo(chemo)therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro 10-9359)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Hydroxyurea in the management of therapy resistant psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Hydroxyurea. A new treatment for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

PUVA and cancer risk: the Swedish follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Clinical pharmacologic observations on 6-mercaptopurine and 6-methylthiopurine ribonucleoside

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

A multicenter dose-escalation trial with denileukin diftitox (ONTAK, DAB(389)IL-2) in patients with severe psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Evidence that a locus for familial psoriasis maps to chromosome 4q

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Rapamycin: FK506's fraternal twin or distant cousin?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Treatment of severe psoriasis with anti-CD25 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Clinical clearing of psoriasis by 6-thioguanine correlates with cutaneous T-cell depletion via apoptosis: evidence for selective effects on activated T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Family history, smoking habits, alcohol consumption and risk of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Fumaric acid therapy in psoriasis: a double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid ester.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Fumaric acid therapy for psoriasis: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Psoriasis and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Successful treatment of severe psoriasis with basiliximab, an interleukin-2 receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Action Spectrum for Phototherapy of Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Pulmonary complications following methotrexate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Acitretin. A review of its pharmacology and therapeutic use

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Tacrolimus ointment improves psoriasis in a microplaque assay

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Hepatotoxicity of methotrexate in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Methotrexate in psoriasis: consensus conference

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Photosensitive psoriasis. An epidemiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Successful treatment of severe generalized pustular psoriasis with basiliximab (interleukin-2 receptor blocker)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Skin permeability of anthralin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Relapse rate of psoriasis worsened by adding steroids to a dithranol regime

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Stress and psoriasis: the importance of insight and empathy in prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Biologic therapy for psoriasis: the new therapeutic frontier

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Erythemal and therapeutic response of psoriasis to PUVA using high-dose UVA.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

The development of practice guidelines for the treatment of severe plaque form psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Age at onset and different types of psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Antitumor action of retinoids: inhibition of tumor cell line-induced angiogenesis and prevention of tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Fumaric acid derivatives evoke a transient increase in intracellular free calcium concentration and inhibit the proliferation of human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

High-dose 308-nm excimer laser for the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Methotrexate revisited: effects of long-term treatment in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Suppression of epidermal proliferation by ultraviolet light, coal tar and anthralin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

An approach to the treatment of moderate to severe psoriasis with rotational therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Re-examining crude coal tar treatment for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

Hydroxyurea in the treatment of refractory psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

6-Thioguanine treatment of psoriasis: experience in 81 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900041-X

7 January 2021

10.1016/S0163-7258(03)00041-X

Identifiers

DOI

1 reference

7 August 2017

1 reference